期刊文献+

从糖尿病前期到糖尿病高危:糖调节异常与脑卒中研究最新进展 被引量:10

From Pre-diabetes to Increased Risk for Diabetes-Advance in the Association between Impaired Glucose Regulation and Stroke
暂未订购
导出
摘要 新近流行病学研究表明,由于生活方式的迅速改变,糖尿病已经成为我国的主要公共健康问题。糖尿病能够增加卒中风险2~5倍。空腹血糖受损(impaired fasting glucose,IFG)和糖耐量异常(impaired glucose tolerance,IGT)合称糖尿病前期、糖调节异常或中间型高血糖,也增加卒中风险。胰岛素抵抗,血脂代谢紊乱,凝血和纤溶异常,慢性炎症和血管内皮功能损害是可能机制。在美国糖尿病协会(American Diabetes Association)2010年指南中,"糖尿病高危"代替了"糖尿病前期"的概念,并涵盖了糖化血红蛋白(Hemoglobin A_1c)在5.7%~6.4%之间的患者。随机对照试验证实,对糖尿病高危患者进行干预能够减少糖尿病发病率。同时有研究表明治疗IGT能够减少心血管事件和高血压的发病,这需要进一步研究证实。应该对卒中患者进行筛检,发现糖尿病高危患者并进行干预。 Prospective epidemiological study indicated recently that diabetes has become a major public health problem in China because of the rapid changes in lifestyle. The presence of diabetes increases the risk of stroke 2- to 5-fold. Not only patients with diabetes are at increased risk of stroke but also patients with impaired fasting glucose (IFG) and impaired glucose tolerance (IGT). Underlying pathogenetic mechanisms include insulin resistance, dyslipidemia, procoagulability, impaired fibrinolysis,chronic inflammation and endothelial dysfunction. Pre-diabetes (or intermediate hyperglycaemia) has been renamed "Categories of increased risk for diabetes" in the American Diabetes Association (ADA) Guideline 2010 and Alc range of 5.7-6.4% included as a category of increased risk for future diabetes.Randomized controlled trials(RCTs) have shown that individuals at high risk for developing diabetes (those with IFG, IGT, or both) can be given interventions that significantly decrease the rate of onset of diabetes.Previous study suggested that treating IGT patients is associated with a significant reduction in the risk of cardiovascular disease and hypertension,which need further evaluation.Strategies aimed at screening and treating stroke patients with increased risk for diabetes are needed.
出处 《中国卒中杂志》 2010年第4期332-337,共6页 Chinese Journal of Stroke
基金 国家科技重大专项资助项目(2008ZX09312-008) 国家重点基础研究发展规划资助项目(973计划项目)(2009CB521905)
关键词 糖尿病 卒中 危险因素 一级预防 Diabetes mellitus Stroke Risk factors Primary prevention
  • 相关文献

参考文献37

  • 1Yang W,Lu J,Weng J,et.al.Prevalence of diabetes among men and women in China[J].N Engl J Med,2010,362:1090-1101.
  • 2Goldstein LB,Adams R,Alberts MJ,et al.Primary prevention of ischemic stroke:a guideline from the American Heart Association/American Stroke Association Stroke Council:cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council;Nutrition,Physical Activity,and Metabolism Council;and the Quality of Care and Outcomes Research Interdisciplinary Working Group:the American Academy of Neurology affirms the value of this guideline[J].Stroke,2006,37:1583-1633.
  • 3Sacco RL,Adams R,Albers G,et al.Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack:a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke:co-sponsored by the Council on Cardiovascular Radiology and Intervention:the American Academy of Neurology affirms the value of this guideline[J].Stroke,2006,37:577-617.
  • 4The European Stroke Organisation(ESO)Executive Committee and the ESO Writing Committee.Guidelines for management of ischaemic stroke and transient ischaemic attack 2008[J].Cerebrovasc Dis,2008,25:457-507.
  • 5Expert Committee on the Diagnosis and Classification of Diabetes Meilitus.Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus[J].Diabetes Care,1997,20:1183-1197.
  • 6Genuth S,Alberti KG,Bennett P,et.al.Follow-up report on the diagnosis of diabetes mellitus[J].Diabetes Care,2003,26:3160-3167.
  • 7Bloomgarden ZT.American College of Endocrinology Pre-Diabetes Consensus Conference:part one[J].Diabetes Care,2008,31:2062-2069.
  • 8American Diabetes Association.Standards of medical care in diabetes--2010[J].Diabetes Care,2010,33:11-s61.
  • 9Tanne D,Koren-Morag N,Goldbourt U.Fasting plasma glucose and risk of incident ischemic stroke or transient ischemic attacks:a prospective cohort study[J].Stroke,2004,35:2351-2355.
  • 10Tanne D,Koren-Morag N,Goldbourt U.Fasting plasma glucose and risk of incident ischemic stroke or transient ischemic attacks:a prospective cohort study[J].Stroke,2004,35:2351-2355.

二级参考文献10

  • 1Goldbourt,U,Yaari,S,Medalie,JH.Factors predictive of long-term coronary heart disease mortality among 10,059 male Israeli civil servants and municipal employees[].Cardiology.1993
  • 2Heuschmann PU,Kolominsky-Rabas PL,Misselwitz B,et al.Pre-dictors of in-hospital mortality and attributable risks of death afterischemic stroke:the German Stroke Registers Study Group[].Archives of Internal Medicine.2004
  • 3Tanne D,Kasner SE,Demchuk AM,et al.Markers of in-creased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice:the Multicenter rt-PA Stroke Survey[].Circulation.2002
  • 4Fogelholm R,Murros K,Rissanen A,et al.Admission blood glucose and short termsurvival in primary intracerebral haemorrhage:a popu-lation based study[].Journal of Neurology Neurosurgery and Psychiatry.2005
  • 5.Glucose tolerance and cardiovascular mortality. Comparison of fasting and 2-h diagnostic criteria[].Archives of Internal Medicine.2001
  • 6Goldberg RB,MelliesMJ,Sacks FM, et al.Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivorswith average cholesterol levels: subgroup analyses in the Cholesterol and RecurrentEvents (CARE) trial The CARE Investigators[].Circulation.1998
  • 7Lindholm,LH,Ibsen,H,Dahlof,B.LIFE Study Group. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol[].The Lancet.2002
  • 8Heart Outcomes Prevention Evaluation Study Investigators.Effects of ramipril on cardiovascular and microvascular out-comes in people with diabetes mellitus:results of the HOPEstudy and MICRO-HOPE substudy[].The Lancet.2000
  • 9Colhoun,H.M.,Betteridge,D.J.,Durrington,P.N.CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial[].The Lancet.2004
  • 10Ivey FM,Ryan AS,Hafer-Macko CE,et al.High prevalence of abnormal glucose metabolism and poor sensitivity of fasting plasma glucose in the chronic phase of stroke[].Cerebrovascular Diseases.2006

共引文献5

同被引文献63

引证文献10

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部